Beyza Günaydin

Beyza Günaydin

Auto-generated profile, based on publicly available information

Beyza Günaydin

Faculty of Dentistry, Department of Pediatric Dentistry Tokat Gaziosmanpaşa University Tokat Türkiye

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2026 in International Journal of Paediatric Dentistry
Verified
Journal Article
Open access
PDF file
BGBeyza Günaydin
Beyza Günaydin
CNCanan Bayraktar Nahir
Canan Bayraktar Nahir
NŞNECIBE DAMLA ŞAHIN
NECIBE DAMLA ŞAHIN
Background: Computer‐controlled anesthesia delivery systems (CCLADs), such as SleeperOne, are available as an alternative to traditional anesthesia for the treatment of teeth with molar incisor hypomineralization (MIH). Aim: This study aimed to evaluate the effects of the SleeperOne and the conventional local anesthesia technique on pain and anxiety in children with MIH. Design: Twenty‐eight children aged 6–12 were included in the study. Patients were divided into 2 groups ( n = 28): Conventional anesthesia group and SleeperOne group. The Children's Fear Survey Schedule–Dental Subscale (CFSS‐DS) was administered to all participants prior to treatment. Pain and anxiety levels were assessed using both objective measures (pulse rate, oxygen saturation [SpO 2 ], and salivary cortisol levels) and subjective scales (Wong‐Baker Pain Rating Scale [WBS], Visual Analog Scale [VAS], and Face, Legs, Activity, Crying, Consolability Scale [FLACC]). Results: Cortisol levels were significantly higher in the conventional anesthesia group ( p < 0.001). In the after treatment values, mandibular cortisol levels in participants without hypersensitivity and total cortisol levels in participants with hypersensitivity were significantly lower in the SleeperOne anesthesia group ( p = 0.009 and p = 0.017). Conclusions: Lower salivary cortisol levels, a physiological marker of stress, were observed in the SleeperOne group during the treatment of MIH‐affected teeth. Trial Registration: ClinicalTrials.gov : NCT07268157